Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Neuro-Oncology Advances
|
February 4, 2022
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
Baptiste Sourty, Laure-Marie Dardaud, Céline Bris, et al.
International Journal of Cancer
|
February 10, 2010
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
Nicolas Clere, Isabelle Corre, Sébastien Faure, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2011
Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients
Nicolas Azzopardi, Thierry Lecomte, David Ternant, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 26, 2026
Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis
Alexandre Harlé, Léa Payen, Alexandra Lespagnol, et al.
Biomedicines
|
January 8, 2025
Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data
Elena Spirina Menand, Manon De Vries-Brilland, Leslie Tessier, et al.
Plos One
|
February 12, 2014
A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer
Marine Pesson, Alain Volant, Arnaud Uguen, et al.
Skin Health and Disease
|
December 3, 2024
T-cell-related skin inflammatory flareups with Th1 polarity in a patient with pseudoxanthoma elasticum
Samuel Rocour, Emeline Vinatier, Céline Fassot, et al.
Nature Communications
|
December 9, 2021
Acetoacetate protects macrophages from lactic acidosis-induced mitochondrial dysfunction by metabolic reprograming
Clément Adam, Léa Paolini, Naïg Gueguen, et al.
Seminars in Oncology
|
April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
BMC Cancer
|
March 18, 2011
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
Patrice Cellier, Bernard Leduc, Laurent Martin, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Neuro-Oncology Advances
|
February 4, 2022
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
Baptiste Sourty, Laure-Marie Dardaud, Céline Bris, et al.
International Journal of Cancer
|
February 10, 2010
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
Nicolas Clere, Isabelle Corre, Sébastien Faure, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2011
Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients
Nicolas Azzopardi, Thierry Lecomte, David Ternant, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 26, 2026
Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis
Alexandre Harlé, Léa Payen, Alexandra Lespagnol, et al.
Biomedicines
|
January 8, 2025
Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data
Elena Spirina Menand, Manon De Vries-Brilland, Leslie Tessier, et al.
Plos One
|
February 12, 2014
A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer
Marine Pesson, Alain Volant, Arnaud Uguen, et al.
Skin Health and Disease
|
December 3, 2024
T-cell-related skin inflammatory flareups with Th1 polarity in a patient with pseudoxanthoma elasticum
Samuel Rocour, Emeline Vinatier, Céline Fassot, et al.
Nature Communications
|
December 9, 2021
Acetoacetate protects macrophages from lactic acidosis-induced mitochondrial dysfunction by metabolic reprograming
Clément Adam, Léa Paolini, Naïg Gueguen, et al.
Seminars in Oncology
|
April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
BMC Cancer
|
March 18, 2011
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
Patrice Cellier, Bernard Leduc, Laurent Martin, et al.
Page
of 7